Blast crisis

Blast crisis


Blast crisis is the final phase in the evolution of CML,.

In this phase CML behaves like an acute leukemia,

  • rapid progression
  • short survival.
BLAST CRISIS – DIAGNOSISAny of the following present in CML
120% blasts in the blood or bone marrow
2Extramedullary proliferation of blasts
BLAST CRISIS
Imatinib Useful in Blast crisis of CML
inhibitor targeted at the BCR-ABL tyrosine kinase
BCR-ABL expression can be reduced by imatinib to very low or nondetectable levels
Median survival in chronic phase is estimated at a median of 25 to 30 years.
BC has been reduced to 1% to 1.5% per year
Imatinib in CML

Chronic myelogenous leukemia

Imatinib – inhibitor targeted at the BCR-ABL tyrosine kinase

Imatinib – has fundamentally changed treatment of CML.

BCR-ABL expression can be reduced by imatinib to very low or nondetectable levels in the majority of patients.

Median survival in chronic phase is estimated at a median of 25 to 30 years.

Progress to advanced phase CML or BC has been reduced to 1% to 1.5% per year

Blast Crisis Symptoms
1night sweats
2weight loss
3fever
4bone pain
5symptoms of anemia
Blast Crisis Symptoms

Blast crisis is associated with – additional cytogenetic aberrations (ACAs) in addition to the Philadelphia (Ph)–chromosome.

Blast crisis is associated with – additional cytogenetic aberrations with Philadelphia (Ph)–chromosome

Most frequent are the so called “major route” ACA
1Trisomy 8
2Additional Ph-chromosome
3Isochromosome (17q)
4Trisomy 19)
cytogenetic aberrations (ACAs) in addition to the Philadelphia (Ph)–chromosome

which are nonrandom and considered relevant for the pathogenesis of BC

    Subscribe Medicine Question BankWhatsApp Channel

    FREE Updates, MCQs & Questions For Doctors & Medical Students

      Medicine Question Bank
      Enable Notifications OK No thanks